# Cipla, Ltd. – FDA Inspection, Nov 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/cipla-ltd/b1e0ddaa-e91a-4c49-ad50-4b8628dd7563
Source feed: FDA_Inspections

> FDA inspection 1073182 of Cipla, Ltd., November 30, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073182
- Company Name: Cipla, Ltd.
- Inspection Date: 2018-11-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1236690 - 2024-05-08
- [FDA Inspection 1084973 - 2019-03-20](https://www.keypedia.com/records/fda_inspections/cipla-ltd/764f7c2a-e451-45ce-b59f-335b801752d6)
- [FDA Inspection 997481 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/cipla-ltd/0150dc7b-0ea7-4467-9129-865c909e274d)
- FDA Inspection 882706 - 2014-05-23
- FDA Inspection 755727 - 2011-12-01

## Related Officers

- [Company Rep](https://www.keypedia.com/people/rozelle-g-smith/cd2488c0-fe18-4fc4-a80e-20d08a8d12cc)

Company: https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c